D - 80336 München
Phone: Tel: +49 89 2180 72793
- ensuring fair allocation (164 KByte)
- COVID 19 Ethics ConsultationMarch22 (106 KByte)
- Ethics_Global Response (313 KByte)
- Lancet_Response2020Ahmad et al (49 KByte)
- Policy Brief_Pandemic Ethics GeneralF (375 KByte)
- sueddeutsche_challenge (77 KByte)
Verina Wild works in the area of medical ethics/bioethics, public health ethics and global health ethics. Her current research focus is on ethical, legal and social aspects of mobile health technologies.
------ Current COVID-19 related activities --------------------------------------------------------------
The COVID-19 Ad hoc public health ethics consultation, March 22, 2020 for a Bavarian health authority
led to publication as a Journal of Medical Ethics Blog post, April 1, 2020: "Clinical ethics consultations are a well established method to deal with ethically problematic situations in clinical care, even in emergency situations. But an emergency public health ethics consultation? This was unusual for most of us..."
Publication in German: "Covid-19: Eine Ad hoc Public-Health-Ethikberatung / Covid-19: An ad hoc public health ethics consultation" will follow soon, Gesundheitswesen 2020; 82 : 507 – 513
Response about what it means to be made vulnerable to an editorial in The Lancet: Ahmad A, Chung R et al. "What does it mean to be made vulnerable in the era of COVID-19?" The Lancet. 9. Mai 2020;395(10235):1481–2.
Nijsingh N, van Bergen A, Wild V: "Applying a precautionary approach to mobile contact tracing for Covid-19: the value of reversibility" forthcoming in Journal of Bioethical Inquiry
In Sueddeutsche Zeitung on Covid-19 challenge experiments, 11.06.2020
On April 2, 2020 Verina Wild was appointed to represent the German Academy of Medical Ethics (AEM) at the German Public Health Network Covid-19 Together with Jan-Christoph Heilinger and Georg Marckmann she coordinates the Ethics working group. This international group is producing policy briefs on different public health ethics questions:
- Policy Brief on general Public Health Ethics principles and values in the response to Covid-19, 22.04.2020
- Ethical Principles for the Global Corona Response: A policy brief on general ethical principles for the global response against Covid-19 to inform policy makers, the World Health Organization and other stakeholders involved in the “Access to COVID-19 Tools Partnership”.
- Ensuring fair allocation of a SARS-CoV-2 Vaccine: A policy brief with guidance on allocation of a SARS-CoV-2 vaccine to inform policy makers, the World Health Organization and other stakeholders involved in the “Access to COVID-19 Tools Partnership”.
- Policy Brief on Vaccination Policy - Ethical perspectives on a future vaccination program against COVID-19 in Germany, 22.05.2020
PD Dr. Verina Wild is deputy director at the Institute of Ethics, History and Theory of Medicine at Ludwig-Maximilians-University of Munich (LMU). Since April 2018 she has been leading the BMBF research group „META - mHealth: Ethical, legal and social aspects in the technological age“. She teaches medical ethics, public health ethics and global health ethics at the Universities in Munich, Zurich and Bern. She wrote her "Habilitation" with the title "Justice and Vulnerability in Bioethics" at the University of Zurich where she has held a position of a Senior Teaching and Research Associate and Deputy Director (intermittently) from 2008-2016 at the Institute of Biomedical Ethics and History of Medicine. Her medical dissertation was on ethical aspects of clinical drug trials during pregnancy and is published at the publishing house Campus. Prior to becoming a scholar in health ethics she has worked as a physician in internal medicine in Berlin, Germany and gathered work experience in Tanzania, Scotland, Spain and Argentina.
Awards and fellowships
- 2018: Princess Therese von Bayern-Award (LMU) for outstanding performance in research and teaching
- 2017: DFG Fellowship at “Sydney Health Ethics", University of Sydney, Australia
- 2011: SNSF Fellowship at “Center for the History and Ethics of Public Health” Columbia University New York, USA
- 2006: Young Scholar Award from the Academy of Ethics in Medicine AEM, Germany
- 2003-2004: Carlo Schmid / DAAD Fellowship Ethics Unit of World Health Organization, Geneva, Switzerland
Memberships and functions
- Since 2018: Member of the Core Group Global Health at the Center of Advanced Studies (CAS), LMU
- Since 2018: Co-founder of working group (AG) public health ethics/global health ethics at Deutsche Gesellschaft für Public Health (DGPH), Co-founded with Prof. Peter Schröder-Bäck
- Since 2017: Member of international Consortium on Vulnerability and Equity in Humanitarian Responses (COVEHR), partly funded by Wellcome Trust, UK
- Since 2016: Member of international network Migration and Health Network Southern Africa (MaHp)
- Since 2015: Member of WHO working groups on Antimicrobial Resistance and Ethics; Revision of Ethics Guidelines for Prevention and Treatment of Tuberculosis (Section: Migration); Health Systems Research and Ethics
- Since 2015: Liaison professor for the Heinrich-Böll-Stiftung
- Since 2015: Member Editorial Board of the Journal Public Health Ethics (Oxford Journals)
- 2011 – 2015: Ethical Advisor for Safety Board for the EU-FP-7 Project „Diabetes and Pregnancy Vitamin D and Lifestyle Intervention for Gestational Diabetes Mellitus Prevention (DALI)“
- 2014 – 2017: Member of working group Ethics in Transplantationmedicine at the German Bundesärztekammer
- 2008 – 2016: Member of the Steering Committee Center for Ethics, University of Zurich
- 2008 – 2013: Country Representative Switzerland for the International Network on Feminist Approaches to Bioethics (FAB)
- 2008 – 2010: Clinical ethicist (intermittendly) and deputy director of clinical ethics committee, Clinical Ethics, University Hospital Zurich
Current memberships: Academy for Ethics in Medicine, Germany (AEM); International Association of Bioethics (IAB); Center for Ethics, LMU Munich; Deutsche Gesellschaft für Public Health (DGPH)